Scientists have discovered a new target for the fight against multi-resistant mycobacteria, from a rejuvenated antibiotic series. Mycobacterium tuberculosis is the main cause of tuberculosis. The treatment for drug-susceptible tuberculosis consists of the daily administration of multiple drugs for a minimum of six months. Lack of adherence to this regimen can result in treatment failure and the emergence of drug resistance.
Scientists have discovered a new target for the fight against multi-resistant mycobacteria, from a rejuvenated antibiotic series. Mycobacterium tuberculosis is the main cause of tuberculosis. The treatment for drug-susceptible tuberculosis consists of the daily administration of multiple drugs for a minimum of six months. Lack of adherence to this regimen can result in treatment failure and the emergence of drug resistance.
Share this Article
Recommended